XML 57 R47.htm IDEA: XBRL DOCUMENT v3.21.1
Share-Based Compensation and Capital Stock - Summary of Change in Stock-Based Award Activity (Details)
3 Months Ended
Mar. 31, 2021
$ / shares
shares
Stock options  
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding [Roll Forward]  
Outstanding, beginning balance (in shares) | shares 819,610
Granted (in shares) | shares 280,811
Exercised/vested (in shares) | shares (48,237)
Expired (in shares) | shares 0
Forfeited (in shares) | shares 0
Outstanding, ending balance (in shares) | shares 1,052,184
Options exercisable, ending balance (in shares) | shares 556,285
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price [Abstract]  
Beginning balance - weighted average exercise price (in dollars per share) | $ / shares $ 70.48
Granted - weighted average exercise price (in dollars per share) | $ / shares 104.87
Exercised/vested - weighted average exercise price (in dollars per share) | $ / shares 59.00
Expired - weighted average exercise price (in dollars per share) | $ / shares 0
Forfeited - weighted average exercise price (in dollars per share) | $ / shares 0
Ending balance - weighted average exercise price (in dollars per share) | $ / shares 80.19
Options exercisable, ending balance - weighted average exercise price (in dollars per share) | $ / shares $ 65.32
Share-based Compensation Arrangement by Share-based Payment Award, Options, Weighted Average Remaining Contractual Term [Roll Forward]  
Weighted average remaining contractual term - outstanding, ending balance 5 years 8 months 12 days
Weighted average remaining contractual term - options exercisable, ending balance 3 years 1 month 6 days
Restricted Stock  
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested [Roll Forward]  
Outstanding, beginning balance (in shares) | shares 304,439
Granted (in shares) | shares 43,607
Exercised/vested (in shares) | shares (84,711)
Forfeited (in shares) | shares (5,998)
Outstanding, ending balance (in shares) | shares 257,337
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract]  
Beginning balance - weighted average grant date fair value (in dollars per share) | $ / shares $ 84.48
Granted - weighted average grant date fair value (in dollars per share) | $ / shares 105.24
Exercised/vested - weighted average grant date fair value (in dollars per share) | $ / shares 82.20
Forfeited - weighted average grant date fair value (in dollars per share) | $ / shares 82.63
Ending balance - weighted average grant date fair value (in dollars per share) | $ / shares $ 88.79
Performance Vested Restricted Stock Units  
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested [Roll Forward]  
Outstanding, beginning balance (in shares) | shares 321,752
Granted (in shares) | shares 96,447
Performance-based leveraging (in shares) | shares 920
Exercised/vested (in shares) | shares (3,986)
Expired (in shares) | shares (72,944)
Forfeited (in shares) | shares (1,003)
Outstanding, ending balance (in shares) | shares 341,186
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract]  
Beginning balance - weighted average grant date fair value (in dollars per share) | $ / shares $ 109.25
Granted - weighted average grant date fair value (in dollars per share) | $ / shares 108.52
Performance-based leveraging - weighted average grant date fair value (in dollars per share) | $ / shares 81.55
Exercised/vested - weighted average grant date fair value (in dollars per share) | $ / shares 81.55
Expired - weighted average grant date fair value (in dollars per share) | $ / shares 81.55
Forfeited - weighted average grant date fair value (in dollars per share) | $ / shares 97.68
Ending balance - weighted average grant date fair value (in dollars per share) | $ / shares $ 113.22